Skip to main content
logo
Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.300
-0.080 (-3.36%)
At close: Jun 29, 2026, 4:00 PM EDT
2.310
+0.010 (0.43%)
Pre-market: Jun 30, 2026, 6:20 AM EDT

Grace Therapeutics Balance Sheet

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
16.9822.1323.0127.8830.34
Short-Term Investments
---0.0213.32
Cash & Short-Term Investments
16.9822.1323.0127.8943.66
Cash Growth
-23.30%-3.79%-17.52%-36.12%-28.11%
Accounts Receivable
0.020.130.720.80.55
Other Current Assets
0.380.450.280.61.07
Total Current Assets
17.3822.7124.0129.2945.28
Net Property, Plant & Equipment
0.010.020.020.570.57
Other Intangible Assets
41.1341.1341.1341.1369.81
Goodwill
8.148.148.148.1412.96
Total Assets
66.6571.9973.379.12128.62
Accounts Payable
2.151.931.683.343.16
Current Portion of Leases
---0.080.1
Total Current Liabilities
2.151.931.683.413.26
Long-Term Leases
---0.410.19
Other Long-Term Liabilities
0.613.459.877.3516.9
Total Long-Term Liabilities
0.613.459.877.7617.09
Total Liabilities
2.765.3811.5611.1720.35
Common Stock
00261.04258.29257.99
Additional Paid-in Capital
298.41293.3317.8613.9712.15
Accumulated Other Comprehensive Income
-6.04-6.04-6.04-6.04-6.04
Retained Earnings
-228.48-220.69-211.12-198.27-155.84
Shareholders' Equity
63.966.6161.7467.96108.27
Total Liabilities & Equity
66.6571.9973.379.12128.62
Total Debt
0000.490.3
Net Cash (Debt)
16.9822.1323.0127.4143.37
Net Cash Growth
-23.30%-3.79%-16.05%-36.80%-28.49%
Net Cash Per Share
1.031.832.413.697.06
Book Value
63.966.6161.7467.96108.27
Book Value Per Share
3.875.516.489.1417.63
Tangible Book Value
14.6317.3412.4818.6925.5
Tangible Book Value Per Share
0.891.431.312.514.15
SEC Filings: 10-K · 10-Q